Two Highly Antigenic Sites in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1993 Mar 1

PMID 7681439

Authors

E Bjorling

C A Boucher

A Samuelsson

T F Wolfs

G Utter

E Norrby

F Chiodi

Affiliations

Soon will be listed here.

Abstract

Antibodies to human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) are found in the serum of the majority of infected individuals, and inhibition of RT polymerase activity by HIV-1-positive sera can be demonstrated in vitro. The binding sites of human antibodies on the protein have not yet been identified. We synthesized overlapping peptides covering the entire RT protein of HIV-1 and used them in an enzyme-linked immunosorbent assay system to map the reactivities of HIV-1 and HIV-2 antibody-positive sera. Two highly antigenic regions were identified by both HIV serotypes. One region was found in the central part of the RT protein (amino acids 261 to 280) and another was found at the carboxy terminus in the RNase H portion of RT (amino acids 517 to 536). Comparison of the serological results with the crystal structure of the RT revealed that the antigenic region in the RNase H portion is located at the surface of the protein. The other antibody-binding site (amino acids 261 to 280) was located in the "thumb" region of the polymerase domain of RT. Polyclonal antibodies to either of the antibody-binding sites do not affect the polymerase activity of the RT protein.

References

Chou P, Fasman G . Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978; 47:45-148. DOI: 10.1002/9780470122921.ch2. View

Kohlstaedt L, Wang J, Friedman J, Rice P, Steitz T . Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992; 256(5065):1783-90. DOI: 10.1126/science.1377403. View

KYTE J, Doolittle R . A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982; 157(1):105-32. DOI: 10.1016/0022-2836(82)90515-0. View

Houghten R . General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985; 82(15):5131-5. PMC: 390513. DOI: 10.1073/pnas.82.15.5131. View

Wong-Staal F, Shaw G, Hahn B, Salahuddin S, Popovic M, Markham P . Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science. 1985; 229(4715):759-62. DOI: 10.1126/science.2992084. View

Di Marzo Veronese F, Copeland T, Devico A, Rahman R, Oroszlan S, Gallo R . Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science. 1986; 231(4743):1289-91. DOI: 10.1126/science.2418504. View

Allan J, Coligan J, Lee T, Barin F, Kanki P, Mboup S . Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood. 1987; 69(1):331-3. View

Laurence J, Saunders A, Kulkosky J . Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity. Science. 1987; 235(4795):1501-4. DOI: 10.1126/science.2435004. View

Asjo B, Ivhed I, Gidlund M, Fuerstenberg S, Fenyo E, Nilsson K . Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology. 1987; 157(2):359-65. DOI: 10.1016/0042-6822(87)90278-9. View

10.

Larder B, Purifoy D, Powell K, Darby G . Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature. 1987; 327(6124):716-7. DOI: 10.1038/327716a0. View

11.

Hansen J, Schulze T, Moelling K . RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus. J Biol Chem. 1987; 262(26):12393-6. View

12.

Larder B, Purifoy D, Powell K, Darby G . AIDS virus reverse transcriptase defined by high level expression in Escherichia coli. EMBO J. 1987; 6(10):3133-7. PMC: 553754. DOI: 10.1002/j.1460-2075.1987.tb02623.x. View

13.

Sano K, Lee M, Morales F, Nishanian P, Fahey J, Detels R . Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus. J Clin Microbiol. 1987; 25(12):2415-7. PMC: 269505. DOI: 10.1128/jcm.25.12.2415-2417.1987. View

14.

Hansen J, Schulze T, Mellert W, Moelling K . Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J. 1988; 7(1):239-43. PMC: 454263. DOI: 10.1002/j.1460-2075.1988.tb02805.x. View

15.

Padberg C, Nowlan S, Mermer B . Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome. AIDS Res Hum Retroviruses. 1989; 5(1):61-71. DOI: 10.1089/aid.1989.5.61. View

16.

Basu A, Tirumalai R, Modak M . Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5'-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain. J Biol Chem. 1989; 264(15):8746-52. View

17.

Muller B, Restle T, Weiss S, Gautel M, Sczakiel G, Goody R . Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli. J Biol Chem. 1989; 264(24):13975-8. View

18.

Advani M, IMAGAWA D, Lee M, Sano K, Morales F, Mitsuyasu R . Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome. J Clin Microbiol. 1989; 27(7):1453-5. PMC: 267592. DOI: 10.1128/jcm.27.7.1453-1455.1989. View

19.

Mizrahi V, Lazarus G, Miles L, Meyers C, Debouck C . Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities. Arch Biochem Biophys. 1989; 273(2):347-58. DOI: 10.1016/0003-9861(89)90493-1. View

20.

Wolfs T, Geelen J, Schellekens H, Barin F, Dekker J, Goudsmit J . Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection. AIDS Res Hum Retroviruses. 1989; 5(5):535-40. DOI: 10.1089/aid.1989.5.535. View